Caveolin-1 (Cav-1) interacts with large conductance Ca 2+ -activated potassium channels (BKCa) and likely exerts a negative regulatory effect on the channel activity. We investigated the role of Cav-1 in modulating BK(Ca) channel-mediated, endothelium-derived hyperpolarizing factor (EDHF)-dependent arteriolar dilation in normal condition and in an experimental model of obesity.
Introduction
A crucial role for the nitric oxide (NO)-and prostacyclin-independent component of endothelium-dependent dilation has been demonstrated in microvessels. In the presence of inhibitors of NO and prostacyclin synthesis, hyperpolarization of microvascular smooth muscle cells is attributed to endothelium-derived hyperpolarizing factor (EDHF). The exact nature and origin of EDHF are still debated, but there is an accepted view that opening of Ca 2+ -activated potassium [K(Ca)] channels mediate the response. 1 Correspondingly, previous studies demonstrated that increases in Ca 2+ concentration result in opening of small and intermediate conductance K(Ca) channels [SK(Ca) and IK(Ca)] in endothelial cells, which were found to be essential for EDHF-mediated arteriolar dilations. 2 -6 Functional expression of large conductance K(Ca) channels [BK(Ca)] in vascular smooth muscle cells is also implicated in EDHF-mediated arterial responses, 3, 7 but their contribution remains controversial. There are earlier studies showing no or minimal involvement of BK(Ca) channels in mediating the EDHF response. 8 A recent study has found that the contribution of BK(Ca) channels to the EDHF response may vary with the size of vessels, having a greater contribution in larger, first-order mesenteric arteries and no contribution in smaller, fourth-order mesenteric arterioles, even though expression of BK(Ca) channels were similar in the two types of vessels. 9 The underlying mechanisms for these aforementioned discrepant observations remained obscure. Several recent studies strive on elucidating mechanisms by which BK(Ca) channels are regulated under physiological and pathological conditions. Among potential mechanisms, compartmentalizationdependent regulation of BK(Ca) channel activity has recently received a great deal of attention. 10 Interestingly, it has been posited that caveolar compartmentalization of specific vascular signalling pathways are required for the EDHF-mediated dilations in the pig coronary artery. 11 Caveolae are 50-100-nm cell membrane invaginations that are composed of several key structural and scaffolding proteins, such as caveolin-1 (Cav-1). 12, 13 A recent study by Saliez et al. 14 has
found that relaxation of mesenteric arteries from Cav-1 knockout mice exhibited a complete loss of EDHF-mediated relaxation. Absi et al. 15 provided evidence that exposure of mesenteric and coronary arteries to methyl-b-cyclodextrin (MbCD), an agent known to disrupt caveolae, diminished SK(Ca) channel-mediated hyperpolarization, whereas IK(Ca)-dependent responses were unaffected. 15 Interestingly, BK(Ca) channels are also targeted to caveolae microdomains, where Cav-1 interacts with BK(Ca) channels through their a-subunit and exerts a negative regulatory effect on the channel activity. 16 -18 The functional consequence of this interaction and its impact on EDHF-mediated arteriolar dilation is not known. Also, it is unclear whether changes in regulatory function of Cav-1 on BK(Ca) channels have an impact on vasomotor activity in pathological conditions. Thus, in this study we set out to examine the role of Cav-1 in modulating the contribution of BK(Ca) channels to EDHF-mediated arteriolar dilations under normal conditions and in an experimental model of obesity.
Methods

Measurement of diameter of isolated, cannulated, and pressurized arterioles
All experimental procedures were approved by the Institutional Animal Care and Use Committee at New York Medical College (Valhalla, NY, USA). The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). After overnight fasting, the animals (mice and rats) were anaesthetized with an intraperitoneal injection of sodium pentobarbital (50 mg/kg) and the gracilis muscle was removed. The animals were then euthanized by an additional injection of sodium pentobarbital (150 mg/kg) and the hearts were excised. With the use of microsurgical instruments and an operating microscope, the second branches of the septal coronary artery and the first branches of the gracilis muscle artery ( 1.5 mm in length) were isolated and transferred into organ chambers containing two glass micropipettes filled with physiological salt solution (PSS), composed of (in mM): 110.0 NaCl, 5.0 KCl, 2.5 CaCl 2 , 1.0 MgSO 4 , 1.0 KH 2 PO 4 , 5.5 glucose, and 24.0 NaHCO 3 , equilibrated with a gas mixture of 10% O 2 and 5% CO 2 , balanced with nitrogen, at pH 7.4. The vessels were cannulated at both ends and the micropipettes were connected with silicone tubing to a pressure servo control system (Living Systems Instrumentation, VT, USA) to set the intraluminal pressure to 80 mmHg. The temperature was set at 378C by a circulating bath temperature controller (Cole Parmer, USA). Changes in arteriolar diameter were continuously recorded with a CCD camera, connected to a microscope (Nikon, Eclipse 80i). 
Experimental model of obesity
In a separate group of experiments 8-weeks-old male Wistar rats were maintained on standard rat chow (n ¼ 20), while one group of rats were fed a high-fat diet (n ¼ 20, rodent diet with 60% of saturated fat, 58Y1, TestDiet, PMI Nutrition) for additional 10 weeks, as described previously. 21, 22 In similar protocols as described above, ACh-induced, EDHFmediated (in the presence of L-NAME and indomethacin) dilations were investigated in isolated coronary arterioles from lean and obese rats after incubation with the BK(Ca) channel inhibitor, IBTX, the SK(Ca) channel inhibitor, apamin or IK(Ca) channel inhibitor, TRAM34. Moreover, ACh-induced dilations were obtained in the presence of CYP450 inhibitor, sulphaphenazole (10 mmol/L). Dilations to cumulative concentrations of the selective BK(Ca) opener NS-1619 were also investigated in coronary arterioles of lean and obese rats.
Other sets of experiments were carried out on isolated coronary arterioles from lean Wistar rats (n ¼ 11). Arterioles were exposed in vitro to MbCD (3 mmol/L for 90 min), an agent known to disrupt caveolae, 11, 15 and ACh-induced dilations (1 nmol/L to 1 mmol/L) were obtained in the absence or in the presence of BK(Ca) inhibitor, IBTX (100 nmol/L). Arteriolar dilations to selective BK(Ca) opener, NS-1619 (100 nmol/L to 10 mmol/L), were also investigated.
Immunohistochemistry
Left ventricular slices from lean (n ¼ 4) and obese Wistar rats (n ¼ 4) were embedded and frozen in OCT compound (Tissue Tek, Electron Microscopy Sciences). Acetone-fixed consecutive sections (10 mm thick) were immunolabelled with a polyclonal anti-Cav-1 primary antibody (dilution 1:50, Sigma) and smooth muscle actin (dilution 1:200, Novocastra) or with a polyclonal anti-BK(Ca) channel (dilution 1:50, Alomone Labs) and smooth muscle actin (dilution 1:200, Novocastra). Immunofluorescent labelling was performed with Alexa-488 or Alexa-597 labelled secondary antibodies (Invitrogen). DAPI was used for nuclear staining. For non-specific binding, the primary antibody was omitted. Images of the sections were collected with an electron multiplying CCD camera (Luca EM -S, Andor) connected to an Olympus BX61 microscope.
Immunoblots
Single coronary arteries (the first-order septal coronary artery, one vessel from each animal) were dissected from the hearts of lean (n ¼ 5) and obese Wistar rats (n ¼ 5), cleared of connective tissue and briefly rinsed in ice-cold PSS. After the addition of 20 ml of Laemmli sample buffer (from Sigma Inc.) tissues were homogenized. Immunoblot analysis was carried out as described before. 22 The primary antibodies used for Caveolin-1 regulates BK(Ca) channels detection of protein expression of Cav-1 (Abcam, dilution 1:1000) were obtained from Sigma Inc. and for detection of BK(Ca) channel (dilution 1:1000) were obtained from Alomone Labs. Horseradish peroxidase (HRP)-labelled anti-rabbit antibody (dilution 1:5000, Amersham) was used as a secondary antibody. Anti-b-actin IgG (dilution 1:5000) obtained from Abcam was used as loading control. Signals were revealed with chemiluminescence and visualized autoradiographically. Optical density of bands was quantified and normalized for b-actin by using NIH image software.
Statistical analysis
Statistical analyses were performed using GraphPad Prism Software (San Diego California USA) by two-way repeated-measures ANOVA followed by Tukey's post-hoc test or Student's t-test as appropriate. Data are expressed as means + SEM. In isolated vessels, agonist-induced arteriolar dilations were expressed as changes in arteriolar diameter as a percentage of the maximal dilation defined as the passive diameter of the vessel at 80-mmHg intraluminal pressure in a Ca 2+ -free medium. P , 0.05 was considered statistically significant.
Results
K(Ca) channels in EDHF-mediated arteriolar dilations in Cav-1 knockout mice
In isolated, pressurized (80 mmHg) gracilis muscle arterioles from Cav-1 knockout mice, ACh-induced, EDHF-mediated dilations (presence of L-NAME and indomethacin) were slightly but significantly augmented, when compared with the responses in the wild-type mice ( Figure 1A ). The EC 50 of ACh found to be also significantly different between the two groups; dilator responses are being more sensitive to ACh stimulation in arterioles of Cav-1 knockout mice, compared with wild types ( Table 2) .
To assess the potential role of BK(Ca) channels in EDHF-mediated vasodilation the selective BK(Ca) channel inhibitor IBTX (100 nM) was used. In comparison with the control responses, IBTX gave rise to a greater reduction in the magnitudes and also increased the effective concentrations of the ACh-induced dilations in Cav-1 knockout mice ( Figure 1C and D) . Correspondingly, we have found that arteriolar dilations to the selective BK(Ca) channel opener, NS-1619 were significantly enhanced in Cav-1 knockout mice, when compared with responses of wild-type animals ( Figure 1B) .
In order to elucidate the role of other K(Ca) channels in the EDHFmediated arteriolar responses, a selective SK(Ca) channel blocker, apamin and in other set of experiments the selective IK(Ca) channel blocker, TRAM-34 were employed. The magnitudes of ACh-induced arteriolar dilations were significantly reduced by apamin, with a greater extent in the wild-type mice, when compared with Cav-1 knockout mice ( Figure 2 and Table 2 ). Presence of apamin also increased the effective concentrations of ACh but there were no significant differences between the two groups of animals ( Table 2) . TRAM-34 also resulted in reduction of the magnitudes of ACh-induced dilations to a similar extent in the wild-type and Cav-1 knockout mice ( Figure 2 and Table 2 ).
K(Ca) channels in EDHF-dependent coronary arteriolar dilation in obese rats
After commencing of high-fat diet for 10 weeks, the body weight, serum insulin, glucose, and total cholesterol levels of rats became significantly greater, when compared with those of rats fed a standard diet ( Table 1) , similar to our previous findings. 21, 22 In coronary arterioles isolated from lean and obese rats no significant difference in the magnitude of ACh-induced, EDHF-mediated dilations were observed ( Figure 3A) . However, the BK(Ca) inhibitor, IBTX elicited a significantly greater reduction in ACh-induced dilation in coronary arterioles of obese rats, than in lean animals ( Figure 3C and  D) . Correspondingly, dilations to the BK(Ca) channel opener NS-1619 were significantly increased in coronary arterioles of obese rats, when compared with lean controls ( Figure 3B) . ACh-induced arteriolar dilations were inhibited by the SK(Ca) channels blocker, apamin or by the IK(Ca) channel blocker, TRAM-34 in lean and obese animals ( Figure 4) . Effective concentrations of the ACh-induced dilations before and after K(Ca) inhibitors were not significantly different between the two groups ( Table 3) . In a separate set of experiments, ACh-induced dilations were also obtained in the presence of CYP450 inhibitor, sulphaphenazole (10 mmol/L). Sulphaphenazole did not affect ACh-induced dilation and effective concentrations of ACh either in lean and obese animals ( Table 3 ).
3.3 Expression of BK(Ca) channels and Cav-1 in coronary arterioles of lean and obese rats Both BK(Ca) channel and Cav-1 expression were detected in coronary arteriolar sections of lean and obese rats by immunohistochemistry. Protein expression of BK(Ca) channels was detected in the smooth muscle layers in both lean and obese rats, as indicated by co-staining with smooth muscle a-actin ( Figure 5A ). In coronary arterioles of lean rats Cav-1 immunostaining was also detected in smooth muscle cells, similar to that of BK(Ca) channel staining ( Figure 5B Figure 5B) .
In order to quantify the changes of the protein expression, western blot analysis was performed in the first-order coronary arteries of lean and obese rats. We found a significant decrease in protein expression of Cav-1, but not in the BK(Ca) channel in coronary arteries isolated from obese rats, when compared with lean controls (Figure 5C and D) .
Effect of MbCD on EDHF-mediated coronary dilation
Methyl b-cyclodextrin, an agent known to disrupt caveolae, has also been shown to interfere with K(Ca) channel-mediated vasorelaxation. 11, 15 Therefore, in separate experiments ACh-induced, EDHFmediated dilations and also NS-1619-induced responses were examined in coronary arterioles exposed to MbCD (3 mmol/L), in vitro. In arterioles isolated from control, lean rats, MbCD treatment elicited a modest reduction in the magnitude of ACh-induced dilation ( Figure 6A ). Of note, in the presence of MbCD, IBTX inhibited ACh-induced dilation ( Figure 6A ) and also augmented NS-1619-induced response in coronary arterioles of lean rats ( Figure 6B ), similar to that of seen in coronary vessels of obese animals.
Discussion
This study shows that under physiological conditions, Cav-1 limits the contribution of BK(Ca) channels to EDHF-mediated arteriolar dilations, whereas the contribution becomes prominent in the obese rats, a compensatory mechanism, which seems essential for maintained coronary vasodilation in this pathological condition. These conclusions are supported by the findings that: (i) BK(Ca) channels play no or only a minimal role in EDHF-mediated arteriolar dilations in mouse gracilis muscle and rat coronary arterioles under normal condition; (ii) however, the contribution of BK(Ca) channels to EDHF response is prominent in mice with genetic ablation of Cav-1 protein or in normal microvessels after pharmacological disruption of caveolae; and (iii) in coronary arterioles of obese rats a reduced expression of Cav-1 is associated with greater contribution of BK(Ca) channels to the EDHF response. BK(Ca) channels are expressed in almost every tissue and participate in many physiological functions, such as regulation of vascular tone. 7 It is believed that small and intermediate conductance Caveolin-1 regulates BK(Ca) channels to the EDHF response is questioned. 8 Interestingly, Hilgers et al.
9
demonstrated that fourth-order mesenteric arterioles of rats lack BK(Ca) channel involvement in EDHF-mediated dilation, which is present only in larger, first-order mesenteric arteries, even though the expression profile of the pore-forming and regulatory subunits of BK(Ca) channels was similar to the two types of vessels. Moreover, Weston et al. 3 have found that a putative EDHF activates BK(Ca) channels in smooth muscle cells of large, conduit coronary arteries of the pig, an action which shares with 11,12-epoxyeicosatrienoic acid (11, . In the present study we have found that resistance-sized arteries obtained from the two different species (mouse and rat) exhibit a lack of the contribution of BK(Ca) channels to the EDHF response. Moreover, inhibition of cytochrome P450, hence production of EETs, that are believed to be involved in the BK(Ca) channel activation, did not affect EDHF response in these arterioles. Along with the aforementioned study by Hilgers et al. our findings indicate that although BK(Ca) channels are expressed in resistance arteries their function can be mitigated. The molecular mechanism(s), which regulates the contribution of BK(Ca) channels to EDHF response in microvessels, however, remained obscure. It is known that BK(Ca) channels are part of macromolecular signalling complexes that include enzymes and ion channels to mediate local and spatially directed signalling. 10 In this context, Wang et al. 16 provided evidence that BK(Ca) channels are targeted to caveolae microdomains in cultured bovine aortic endothelial cells. Using sucrose gradient cell fractionation and co-immunoprecipitation they demonstrated that BK(Ca) channels are present in the cholesterol-rich lipid rafts and they are physically associated with Cav-1 protein. 16 They also demonstrated that the interaction of Cav-1 with BK(Ca) channels exerts a negative regulatory effect on BK(Ca) channel activation by isoproterenol. 16 Interestingly, in the Cav-1 knockout mice an increased BK(Ca) channel density was found on the cell surface of vascular smooth muscle cells of cerebral arteries, but the magnitude of transient current driven by individual BK(Ca) channels was not different from cells of wild-type animals. 17 Later, Alioua et al.
18
demonstrated that even though Cav-1 and BK(Ca) channels are co-localized at the plasma membrane of smooth muscle cells of the intact rat aorta, this interaction did not alter voltage activation properties of BK(Ca) channels and had no apparent effect on its gating characteristics. Based on these aforementioned studies it has been concluded that Cav-1 physically interacts with BK(Ca) channels, but the inhibitory action by Cav-1 is independent of altering BK(Ca) channel function directly and can be attributed to targeting BK(Ca) channels to caveolae. The functional consequences of the Cav-1 and BK(Ca) channel interaction and caveolae targeting and its impact on EDHF-mediated arteriolar dilation is not known.
In the present study, we have found that the magnitude of EDHFmediated dilations were slightly, but significantly enhanced in gracilis muscle arterioles of the Cav-1 knockout mice, when compared with responses of wild-type animals. More importantly, arterioles from Cav-1 knockout mice exhibited a prominent contribution of BK(Ca) channels to EDHF-mediated arteriolar dilation, which was absent in the wild-type animals. Moreover, the contribution of SK(Ca) channels to EDHF response were reduced in microvessels from Cav-1 knockout mice, a finding similar to that of earlier observation by Absi et al. 15 Thus, it seems Cav-1 protein may contribute to the regulation of various K(Ca) channels either by facilitating their activation state (SK channels) or yielding to their inhibition (BK channels), as demonstrated in the present study in intact resistance arteries. The exact molecular mechanisms behind this regulatory function of Cav-1 are not entirely understood but as pointed out can be attributed to Cav-1-mediated targeting of K(Ca) channels to caveolae, where their activation can be modulated. 16, 18 Considering this scenario, disruption of caveolae alone would mimic the effect of the absent Cav-1 protein on BK(Ca) channel activation. Correspondingly, in the present study we have found that when arterioles from normal animals were exposed to MbCD, an agent known to disrupt caveolae, 11, 15 the contribution of BK(Ca) channels to EDHFmediated arteriolar dilation and also pharmacological activation of BK(Ca) channels become augmented. Thus, we have furnished functional evidence that Cav-1-directed caveolar compartmentalization of BK(Ca) channels is one of the key underlying mechanisms, which leads to their limited contribution to EDHF-mediated arteriolar dilations under normal conditions. In this study we were also interested whether the regulatory function of Cav-1 on K(Ca) channels can be altered in pathological conditions and whether this affects their contribution to EDHFmediated arteriolar dilation. Our recent studies involve the investigation of arteriolar vasomotor dysfunction in obesity and type 2 diabetes. 21 -24 Interestingly, unlike NO, EDHF-mediated arteriolar dilation can persist during the progression of a pathological condition.
In this context, a study by Ellis et al. 25 has found that EDHF-mediated vasodilation was augmented in small mesenteric arteries both in the wild-type and LDL receptor knockout obese mice when fed a high-fat diet. They found that the augmented, EDHF-mediated dilations were effectively blocked by K(Ca) channel inhibitors. 25 On the other hand, in mesenteric arteries of obese, but type 2 diabetic rats, Burnham et al. 26, 27 demonstrated that BK(Ca) and SK(Ca) channel-mediated arteriolar dilation were impaired, but no abnormalities in BK(Ca) and SK(Ca) channel function were detected in younger (5-6 week old) animals. Based on these aforementioned studies existence of certain compensatory mechanism(s) was envisioned, which may maintain or even augment K(Ca) channel function in obesity, especially before the development of type 2 diabetes.
In this study we have tested the specific hypothesis that changes in the regulatory function of Cav-1 on BK(Ca) channels contribute to the maintenance of EDHF-mediated vasodilatation in obesity. Interestingly despite being hyperphagic, Cav-1 knockout mice show overt resistance to diet-induced obesity. 28 Moreover, compared with rats, mice frequently develop hyperglycemia early on in obesity. Therefore, in this study rats were fed a high-fat diet to induce obesity without developing severe hyperglycemia, similar to our recent studies. 21, 22 We have found that coronary arterioles of obese rats exhibited a preserved ACh-induced, EDHF-mediated dilation, when compared with lean controls. Importantly, we demonstrated that the contribution of BK(Ca) channels to the EDHF response and also dilations to the selective BK(Ca) channel opener were significantly augmented in coronary arterioles of obese rats. Thus, it seems that an augmented activation of BK(Ca) channels and their enhanced contribution to EDHF response is one of the mechanisms that may maintain vasodilator function of coronary microvessels in obesity. Then, we have raised the possibility that a loss of the inhibitory action of Cav-1 may be responsible for the augmented contribution of BK(Ca) channels to EDHF-mediated vasodilation in obese rats. Interestingly, we have found that Cav-1 immunostaining was markedly reduced in smooth muscle layers of coronary arterioles of obese rats. In accordance with this observation we have found decreased protein expression Cav-1 in coronary arteries of obese rats, when compared with lean controls. Interestingly reduced vascular expression of Cav-1 has been reported in hypercholesterolemic animals, 29 whereas no change 30 or even increased vascular expression of Cav-1 have been found in animals fed a high-fat diet. 31, 32 Further studies are needed to explain these inconsistent findings and also to elucidate the underlying mechanisms responsible for changes in the vascular expression of Cav-1 in diet-induced obesity. Nevertheless, in view of the proposed inhibitory action of Cav-1 on BK(Ca) channels, a reduced expression of Cav-1 explains the enhanced contribution of BK(Ca) channels to EDHF-mediated coronary dilations in obese rats. It is plausible that a reduced expression of Cav-1 may result in a diminished caveolar localization of BK(Ca) channels, hence facilitating their availability for activation and also contribution to the EDHFmediated vasodilation. Importantly, this mechanism seems essential in maintaining agonist-induced coronary dilations in diet-induced obesity. At this point we can only speculate whether this compensatory response in the coronary arteriolar wall is characteristic to early phases of obesity. Caveolin-1 regulates BK(Ca) channels hemodynamic changes necessitate initial adaptation of the dilator function of coronary resistance vessels that are primarily responsible for adjusting cardiac perfusion to actual metabolic demand. 33 However, such adaptive responses in the coronary circulation may decline as the metabolic disease progresses and other co-morbid diseases develop, such as, severe insulin resistance, hypertension and fasting hyperglycemia (diabetes). This may lead to limited vasodilator function in advanced stages of metabolic disease. In this context it has been shown that in animal models of type 2 diabetes (presence obesity and hyperglycemia) function of BK(Ca) channels 27, 34 and also other K + channels, such as K ATP , 35 SK(Ca) 26 channels is impaired. Taken together, the present study is the first to provide functional evidence for the inhibitory action of Cav-1 on BK(Ca) channels in intact microvessels, which may explain the lack of contribution of BK(Ca) channels to the EDHF response in normal conditions. Because of the loss of the inhibitory action of Cav-1, the contribution of BK(Ca) channels to EDHF-mediated dilations become prominent in diet-induced obesity, a compensatory mechanism, which seems essential for maintained agonist-induced coronary arteriolar dilation. Figure 5 Representative pictures of immunohistochemical staining of BK(Ca) channel (red) and smooth muscle a-actin (SMA, green) are shown in (A), whereas staining of Cav-1 (red) and smooth muscle a-actin (green) are shown in (B), in coronary arterioles of lean (n ¼ 4) and obese rats (n ¼ 4). Merged images show co-staining of BK(Ca) and SMA and also Cav-1 and SMA in the coronary arteriolar wall. DAPI was used to stain the nuclei (blue). Scale bar, 50 mm. (C) and (D) show representative western blots of BK(Ca) channel and Cav-1, respectively, in coronary arteries of lean (n ¼ 5) and obese (n ¼ 5) rats. Anti-b-actin was used to normalize for loading variations. Bar graphs are summary data of normalized densitometry ratios. Figure 6 Percentage dilations of coronary arterioles isolated from lean Wistar rats in response to cumulative concentrations of ACh in the absence or in the presence of methyl-b-cyclodextrin (MbCD) and before and after incubation with iberiotoxin (IBTX) (n ¼ 8 in each group, A). Percentage arteriolar dilations to NS-1619 in the absence or in the presence of MbCD (n ¼ 8, B) . Data are means + SEM. Asterisks indicate significant differences (P , 0.05).
